Latest News Releases From The Newsroom
Supreme Court's Decision Sparks Biden's Call for Inclusive Education
June 30th, 2023
President Biden has announced a series of actions aimed at promoting educational opportunity and diversity in colleges and universities. The recent Supreme Court's decision in two cases — Students for Fair Admissions Inc. (SFFA) v. President an. Read more
Breaking: Renalytix's KidneyIntelX.dkd FDA-Approved, VSE Secures Up to $565M Contract
June 29th, 2023
Shares of Renalytix plc (Nasdaq: RNLX) surged over 25% in after-hours trading following the company's announcement of receiving De Novo marketing authorization from the U.S. Food and Drug Administration (FDA) for its KidneyIntelX.dkd prognostic test.. Read more
Surging and Slumping: Aurinia Pharmaceuticals and Root Make Headlines
June 29th, 2023
Shares of Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH) witnessed a significant surge of over 10% in after-hours trading, driven by the company's announcement of initiating an exploration of strategic alternatives. The Board of Aurinia will carefull. Read more
Earnings Buzz and Reactions: Accolade, Progress Software, and Nike
June 29th, 2023
Accolade, Inc. (Nasdaq: ACCD) released its first-quarter fiscal 2024 earnings report, revealing a loss of $0.52 per share, which was better than the consensus estimate of a loss of $0.62 per share. The company also reported quarterly sales of $93.20 . Read more
SEC Charges Former Pfizer Statistician with Insider Trading Ahead of COVID-19 Announcement
June 29th, 2023
Employee and friend traded ahead of Pfizer’s “game-changer” announcement on the success of its Paxlovid trial FOR IMMEDIATE RELEASE 2022-123 Washington D.C. / CRWE PRESS RELEASE / June 29, 2023 - The Securities and Exch. Read more
BREAKING: BioXcel's Regulatory Inquiry Status Sends Shares Tumbling
June 29th, 2023
Shares of BioXcel Therapeutics, Inc.? (Nasdaq: BTAI) plunged by over 50% in premarket trading following the company's disclosure of a regulatory inquiry into the development of BXCL501, as revealed in a regulatory filing with the SEC. Despite this. Read more
Joby's Pre-Market Surge, Nano Dimension's Milestone Quarter: What You Need to Know
June 29th, 2023
Shares of Joby Aviation, Inc. (NYSE: JOBY) experienced a significant surge of over 10% in pre-market trading following the announcement of an equity investment by SK Telecom Co., Ltd.? (NYSE: SKM), a prominent telecommunications company in South Kore. Read more
Earnings Beat: BlackBerry, Greenbrier, and Acuity Brands in the Spotlight
June 29th, 2023
Shares of BlackBerry Limited (NYSE: BB) experienced a significant surge of over 10% in pre-market trading following the release of better-than-expected financial results. The company delivered a surprise profit for the first quarter of fiscal 2024. Read more
Bullishness: ZI, GPC, SQSP, DE, VVI, WIX, ARRY, GDDY - Top Buy Ratings
June 29th, 2023
ZoomInfo Technologies Inc. (Nasdaq: ZI), a leading provider of go-to-market intelligence solutions, received coverage initiation from Needham with a Buy rating and a price target of $35. Despite closing at $25.61 on Wednesday, the stated pri. Read more
FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes
June 28th, 2023
Silver Spring, MD / CRWE PRESS RELEASE / June 28, 2023 - Today, the U.S. Food and Drug Administration approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor pancreatic cells for the treat. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login